Other Briefings
US Pharma Tariff 2026: Decoding the 100% Patented Drug Levy and the Generic Exemption
The US administration under President Donald J. Trump has implemented a 100% tariff on patented pharma products to curb import dependence. While Indian generics are exempt for now, a one-year review and API onshoring rules signal long-term shifts.
India’s EMI Scheme 2026-2028: New Deferred Customs Duty Facility for Eligible Manufacturer Importers
The Eligible Manufacturer Importers, or EMI scheme, effective from April 1, 2026, to March 31, 2028, allows compliant Indian manufacturers to move from transaction-based payments to a monthly consolidated duty cycle.
India Refines RELIEF Support for West Asia Exports; Focus on Shipments Till June 15
India launched the RELIEF initiative in 2026, with a budgetary outlay of INR 4.97 billion, to support exporters amid West Asia disruptions. Explore ECGC insurance tiers and MSME freight reimbursements.
India’s Crude Oil Tracker 2026: Supply Diversification and Energy Security Measures
With crude prices hitting US$113.57 as of March 11, 2026, is India’s energy supply secure? Learn about the March 2026 Natural Gas Control Order, increased domestic LPG production, and India’s shift to sourcing crude oil from 40 different countries.
India Eases E-commerce Export and Courier Trade Norms from April 1, 2026
Effective April 1, 2026, India modernizes courier trade via the Central Board of Indirect Taxes and Customs (CBIC) notifications 33 & 34/2026. Key updates include removal of export value limits, 15-day re-export options, and enhanced digital monitoring for returned e-commerce shipments.
Beyond Oil: How Gulf Disruptions Are Rewiring Global Supply Chains
The 2026 West Asia conflict has triggered a systemic, multi-sector shock, with disruptions to urea and helium exports from the Gulf constraining global agriculture and semiconductor manufacturing supply chains.
How to Import Restricted Goods in India: DGFT License Process, Documents & Compliance Guide
Following the DGFT’s March 16 notification, certain key commodities have transitioned from “free” to “restricted” status till June 30, 2026. Learn the essential authorization process and documentation required to mitigate any import regulatory risk.
Op-Ed: India’s Calibrated Opening to China-Linked Capital Signals a Pragmatic Shift
India’s recalibration of its land-border investment rules signals a pragmatic shift, loosening elements of Press Note 3 (2020) through the latest FDI revisions issued in March 2026, as New Delhi cautiously opens the door to Chinese capital while retaining strategic screening safeguards.
